Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by InvrsContrarianon Jul 29, 2021 10:22am
225 Views
Post# 33620587

RE:RE:RE:RE:RE:RE:RE:RE:RE:looks like we have nice upsite today

RE:RE:RE:RE:RE:RE:RE:RE:RE:looks like we have nice upsite today Quite right. End user doesn't equal to buyer, and for the billing question that has been taken care of. Vpt has secured a billing code with all the hospitals. It's quite lucrative from one of the many interview given.
Quanadien wrote:
woundedknee wrote: Do the doctors, as individuals, have the discretion to buy on their own? I would say no. This needs to be sold to hospital administrations and larger institutions like the collaboration we now have with GE. On the other hand, you're right, in the sense that doctors are the users and can alert those with the power and purse strings.


Yeah Im pretty sure a doctor cant buy it for himself... must probably need to be approved by administration... also I would say even the administration of the hospital... probably must need to know if insurance would pay for that kind of service. They do pay for MRI as it is known and consider valid. But would they pay for that new kind of service... I think is also to be determined. If insurance companies dont reimburse what VPT technologies gives as information... I doubt management will buy their product as they wont be able to bill for that service. Also... it wouldnt be great news if the sales are mostly individual like (1-2 units per transaction....) I think investors are hoping for a significant number of units sold per transaction (a number I do not know... as we dont even know they sell one for how much.... or maybe you guys got a number $ for a unit??) Glta


<< Previous
Bullboard Posts
Next >>